FDA Approves Updated COVID-19 Shots with Restrictive Use Guidelines
U.S. regulators have approved updated COVID-19 shots from Pfizer, Moderna, and Novavax, but with significant restrictions on their use, particularly for younger adults and children. The new shots, which target a newer version of the continuously evolving virus, are approved for all seniors but only for those with at least one high-risk health condition, such as asthma or obesity, in younger adults and children. Pfizer's vaccine will no longer be available for children under 5, while Moderna's Spikevax vaccine will only be available for children with at least one serious health problem.
Key Takeaways:
- The FDA has approved updated COVID-19 shots from Pfizer, Moderna, and Novavax, but has restricted their use for many Americans.
- The new shots are approved for all seniors, but only for those with at least one high-risk health condition, such as asthma or obesity, in younger adults and children.
- Pfizer's vaccine will no longer be available for children under 5, as the FDA has revoked its emergency authorization for that age group.
- Moderna's Spikevax vaccine will only be available for children with at least one serious health problem.
- The new restrictions reflect ongoing skepticism about the need for yearly COVID-19 booster shots, particularly from Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary.
- The revamped vaccines will begin shipping immediately, but access will be dependent on decisions by federal health advisers, private health insurers, pharmacies, and state authorities.
Statistics:
- The FDA has approved the updated COVID-19 shots for all seniors, regardless of health status.
- The new shots are only approved for younger adults and children with at least one high-risk health condition, such as asthma or obesity.
- Pfizer's vaccine will no longer be available for children under 5.
- Moderna's Spikevax vaccine will only be available for children with at least one serious health problem.
- The new restrictions reflect a change in policy, which previously recommended annual COVID-19 shots for all Americans 6 months and up.
- The updated vaccines target a newer version of the continuously evolving virus.
Sources:
- AP (Matthew Perrone), "FDA Approves Updated COVID-19 Shots with Restrictions"